11/5/2018 Eligibility, clinical outcomes, and budget impact of PCSK9 inhibitors adoption: the CANHEART PCSK9 study Ko DT, Khan AM, Kotrri G, Austin PC, Wijeysundera HC, Koh M, Chu A, Jackevicius CA, Lawler PR, Tu JV. J Am Heart Assoc. 2018; 7:e010007. Epub 2018 Nov 5.
10/29/2018 Factors associated with door-in to door-out delays among ST-segment elevation myocardial infarction (STEMI) patients transferred for primary percutaneous coronary intervention: a population-based cohort study in Ontario, Canada Shi O, Khan AM, Rezai MR, Jackevicius CA, Cox J, Atzema CL, Ko DT, Stukel TA, Lambert LJ, Natarajan MK, Zheng ZJ, Tu JV. BMC Cardiovasc Disord. 2018; 18(1):204. Epub 2018 Oct 29.
10/23/2018 Emergency department volume and outcomes for patients after chest pain assessment Ko DT, Dattani ND, Austin PC, Schull MJ, Ross JS, Wijeysundera HC, Tu JV, Eberg M, Koh M, Krumholz HM. Circ Cardiovasc Qual Outcomes. 2018; 11(11):e004683. Epub 2018 Oct 23.
TCTMD10/26/2018Article Patients with chest pain less likely to die after discharge from high-volume EDs
Stat10/31/2016Article Raising ‘good’ cholesterol doesn’t protect against heart disease after all, study finds